Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS)

November 2012

You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS).

It's not a completely new drug.

It's the active metabolite of leflunomide (Arava, etc)...the immunomodulator used to slow progression of rheumatoid arthritis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote